Latest SPHHP News

  • UB nutrition students hold ‘Picnic Palooza’

    The Clinical Nutrition MS Program's event helps students develop a range of valuable skills in dietetics practice.

  • Nutrition program accredited
    The Clinical Nutrition MS program in the School of Public Health and Health Professions has been accredited by the Accreditation Council for Education in Nutrition and Dietetics, ACEND, for the next seven years, the longest term possible.
  • PT alum sponsors SPHHP’s summer program for high schoolers
    Blue Path brings Western New York high school students interested in health careers to UB for two weeks during the summer to cultivate and refine skills central to thriving careers in epidemiology, health policy and economics, exercise science, occupational therapy, community health, nutrition, dietetics and more.
  • Webinar highlights crucial health-housing link

    A UB faculty member and PhD student addressed challenges from the perspective of the Pan American Health Organization.

  • Two SPHHP Faculty Receive SUNY Chancellor's Awards
    Two faculty members from the School of Public Health and Health Professions have been named recipients of the 2024 SUNY Chancellor’s Award for Excellence.
  • SPHHP Staff and Faculty Awards Given During Annual Meeting
    The University at Buffalo School of Public Health and Health Professions announced the recipients of its 2023-2024 awards during the school’s annual meeting in May. The award recipients have been chosen for their outstanding dedication and service to the school in areas of scholarship, community engagement and professional duties.
  • UB steps up to the challenge

    More than 2,200 participants logged more than 400 million steps during the School of Public Health and Health Profession's 2024 Step Challenge.

  • Reclassification of cannabis

    UB experts weigh in on the DEA's move to reclassify cannabis from a Schedule I to a Schedule III substance.

  • UB experts weigh in on DEA’s reclassification of cannabis

    Rescheduling cannabis would have broad implications, paving the way for more informed research on the drug and its effects, to tax benefits for businesses, to the potential for rectifying drug-related wrongs.